Target Name: NQO2
NCBI ID: G4835
Review Report on NQO2 Target / Biomarker Content of Review Report on NQO2 Target / Biomarker
NQO2
Other Name(s): quinone reductase 2 | Quinone reductase 2 | NAD(P)H dehydrogenase, quinone 2 | NRH:quinone oxidoreductase 2 | Ribosyldihydronicotinamide dehydrogenase [quinone] | DIA6 | NQO2 variant 3 | N-ribosyldihydronicotinamide:quinone reductase 2 | NRH dehydrogenase [quinone] 2 | Ribosyldihydronicotinamide dehydrogenase [quinone] (isoform 1) | NAD(P)H quinone dehydrogenase 2 | ribosyldihydronicotinamide dehydrogenase | NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2 | NMOR2 | QR2 | NQO2_HUMAN | Ribosyldihydronicotinamide dehydrogenase | DHQV | N-ribosyldihydronicotinamide:quinone reductase 2, transcript variant 3

NQO2: A Potential Drug Target and Biomarker for Xenobiotics

Quinone Reductase 2 (NQO2) is a protein that is expressed in various cell types throughout the body. NQO2 plays a crucial role in the detoxification of xenobiotics, which are harmful substances that can cause oxidative stress and damage to cells. NQO2 is a key enzyme in the xenobiotic response pathway, which is a critical system that helps the body to eliminate xenobiotics from its cells.

Recent studies have identified NQO2 as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The NQO2 enzyme has also been identified as a potential biomarker for these diseases, as the levels of NQO2 in cells can be affected by the presence of xenobiotics.

One of the key reasons for the potential drug targeting of NQO2 is its role in the detoxification of xenobiotics. Many xenobiotics, such as polycyclic aromatic hydrocarbons (PAHs) and heterofulvins, can cause oxidative stress and damage to cells. NQO2 is the enzyme that is responsible for detoxifying these xenobiotics, which helps to protect the cell from damage.

In addition to its role in the detoxification of xenobiotics, NQO2 is also involved in the regulation of cellular processes that are important for cell survival. For example, NQO2 is involved in the production of reactive oxygen species (ROS), which can cause damage to cells if they are not properly regulated. Additionally, NQO2 is involved in the production of superoxide, a toxic oxidant that can cause inflammation and contribute to a variety of diseases.

The potential drug targeting of NQO2 is due to its ability to interact with a variety of drug targets. For example, NQO2 has been shown to interact with the drug targets that are involved in cell survival and metabolism. This has led to the idea that NQO2 may be a useful drug target for diseases that are caused by the inhibition of these drug targets.

In addition to its potential drug targeting, NQO2 is also a potential biomarker for a variety of diseases. The levels of NQO2 in cells can be affected by the presence of xenobiotics, which can indicate the presence of these drugs in the body. This has led to the idea that NQO2 may be a useful biomarker for diseases that are caused by the exposure to xenobiotics.

Overall, NQO2 is a protein that is involved in the detoxification of xenobiotics and the regulation of cellular processes. The potential drug targeting of NQO2 is due to its ability to interact with a variety of drug targets and its potential as a biomarker for diseases. Further research is needed to fully understand the role of NQO2 in the body and its potential as a drug and biomarker.

Protein Name: N-ribosyldihydronicotinamide:quinone Reductase 2

Functions: The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinones involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis

The "NQO2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NQO2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2 | NSA2P2 | NSD1 | NSD2 | NSD3 | NSDHL | NSF | NSFL1C | NSFP1 | NSG1 | NSG2 | NSL complex | NSL1 | NSMAF | NSMCE1 | NSMCE1-DT | NSMCE2 | NSMCE3 | NSMCE4A | NSMF | NSRP1 | NSUN2 | NSUN3 | NSUN4 | NSUN5 | NSUN5P1 | NSUN5P2 | NSUN6 | NSUN7 | NT5C | NT5C1A